These results were also observed in a xenograft mice model, where intraperitoneal injections of erinacine A (1–5 mg/kg/day) significantly inhibited tumor volume and increased COFL1 (cofilin-1) and PROF1 (profilin-1) tissue protein expression. This evidence concerns the gene CFL1 and neoplasm.